arrow
X

Xia He

南京医科大学
H指数:57
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study

基于AJCC/UICC第9版TNM分期系统对中国非流行区鼻咽癌N分期的验证与优化:一项多中心队列研究

2026-09-080
OAAI
Capturing “source” and “evolution”: A 5-year recurrence risk prediction model for nasopharyngeal carcinoma based on integrated radiomic spatial heterogeneity of primary tumor and lymph nodes

捕获“来源”和“演变”:基于原发肿瘤和淋巴结综合放射组学空间异质性的鼻咽癌5年复发风险预测模型

2026-04-280
PRE
Bispecific antibodies (PD-1/CTLA-4) vs. PD-1 inhibitors with platinum-based chemotherapy±bevacizumab as first-line therapy for persistent, recurrent, or metastatic cervical cancer: a retrospective matched cohort study

双特异性抗体(PD-1/CTLA-4)与PD-1抑制剂联合铂类化疗±贝伐珠单抗作为持续性、复发性或转移性宫颈癌的一线治疗:一项回顾性匹配队列研究

2025-10-240
OA
Survival benefit of adjuvant radiotherapy following asparaginase-based chemotherapy in patients with chemo-responsive advanced-stage extranodal NK/T-cell lymphoma: A multicenter study using the CLCG database

异位NK/T细胞淋巴瘤患者对化疗有反应的晚期阶段中,辅助放疗在基于门冬酰胺酶的化疗后的生存获益:一项使用CLCG数据库的多中心研究

2025-09-170
PRE